e-learning
resources
Munich 2014
Wednesday, 10.09.2014
COPD markers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bacterial resistance induction with prophylactic antibiotics in COPD
S. Brill, M. Law, J. Allinson, E. El-Emir, T. McHugh, G. Donaldson, D. Jackson, M. Sweeting, W. Wedzicha (London, Cambridge, United Kingdom)
Source:
International Congress 2014 – COPD markers
Session:
COPD markers
Session type:
Poster Discussion
Number:
4731
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Brill, M. Law, J. Allinson, E. El-Emir, T. McHugh, G. Donaldson, D. Jackson, M. Sweeting, W. Wedzicha (London, Cambridge, United Kingdom). Bacterial resistance induction with prophylactic antibiotics in COPD. Eur Respir J 2014; 44: Suppl. 58, 4731
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014
Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Infective exacerbations of COPD. Relation between the bacteriologic etiology and severity of the disease
Source: International Congress 2014 – COPD markers
Year: 2014
Inter-relationship of different types of respiratory symptoms in COPD
Source: International Congress 2014 – Comorbidities
Year: 2014
Clinical, functional and laboratory assessment of treatment efficacy in COPD patients
Source: International Congress 2014 – Predictors
Year: 2014
Antibiotic resistance in ambulatory patients with chronic obstructive pulmonary disease–clinical signs
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability
Source: International Congress 2014 – Markers
Year: 2014
Genetic determinants of oropharyngeal streptococci antimicrobial resistance in COPD patients and asthma sufferers
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Bacterial profile and antibiotic susceptibility from patients with exacerbation of COPD: 10 – years prospective study
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Identification of nasal virus infection in patients with COPD exacerbations
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Integrated care reduces hospital utilization among patients with severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Antimicrobial profile and bacterial resistance in patients wit acute exacerbation of COPD, an Upper Egypt multicenters experience
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes
Source: International Congress 2014 – Markers
Year: 2014
COPD and depression: Prevalence and interaction
Source: International Congress 2014 – Comorbidities
Year: 2014
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Acute exacerbations of COPD due to pseudomonas aeruginosa: Impact of antimicrobial resistance
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
Mortality predictors in stable COPD
Source: International Congress 2014 – Predictors
Year: 2014
Distribution and outcomes of the new Spanish phenotype-based guideline for COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept